Chemoinformaics analysis of Ethanone, 1-(2-methyl-1-cyclopenten-1-yl)-
| Molecular Weight | 124.183 | nRot | 1 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 6 |
| Exact Molecular Weight | 124.089 | nRing | 1 |
| Solubility: LogS | -1.741 | nHRing | 0 |
| Solubility: LogP | 1.75 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 22.1635 |
| nHD | 0 | BPOL | 12.9065 |
| QED | 0.523 |
| Synth | 2.602 |
| Natural Product Likeliness | 0.59 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.044 |
| Pgp-sub | 0.003 |
| HIA | 0.007 |
| CACO-2 | -4.46 |
| MDCK | 0.0000266 |
| BBB | 0.349 |
| PPB | 0.815112 |
| VDSS | 0.746 |
| FU | 0.354436 |
| CYP1A2-inh | 0.908 |
| CYP1A2-sub | 0.942 |
| CYP2c19-inh | 0.59 |
| CYP2c19-sub | 0.716 |
| CYP2c9-inh | 0.159 |
| CYP2c9-sub | 0.579 |
| CYP2d6-inh | 0.603 |
| CYP2d6-sub | 0.377 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.407 |
| CL | 5.758 |
| T12 | 0.787 |
| hERG | 0.011 |
| Ames | 0.021 |
| ROA | 0.335 |
| SkinSen | 0.57 |
| Carcinogencity | 0.653 |
| EI | 0.98 |
| Respiratory | 0.757 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.949385 |